Not Yet Recruiting
Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With Schizophrenia
NCT07615075
- Conditions
- Healthy, Mental Disorders, Psychotic Disorders, +3 more
- Locations
-
- Maryland Psychiatric Research Center (MPRC) Outpatient Research Program (ORP); the MPRC Treatment Research Program (TRP) Catonsville, Maryland, United States